The tariff classification of Hinscope from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the Hinscope will be 9018.19.9550, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[i]nstruments and appliances used in medical, surgical, dental or veterinary sciences …: [e]lectro-diagnostic apparatus …: [o]ther: [o]ther: [o]ther: [o]ther apparatus.” The general rate of duty will be free.
Ruling text
In your letter dated September 7, 2025, you requested a tariff classification ruling. Hinscope consists of a vital sign measurement unit worn on the patient’s upper arm, and a mobile application. The vital sign measurement unit is a combination of optical sensors and a sphygmomanometer cuff which provide measurements of the patient’s pulse rate (PR) oxygen saturation (SpO2), and non-invasive blood pressure (NIBP). PR and SpO2 are measured using a photoplethysmography (PPG) optical measurement method.
PPG is a non-invasive technology that uses light sources (green, red, and infrared) and photodetectors at the surface of skin to measure the volumetric variations of blood circulation. Blood pressure is measured with the sphygmomanometer using an algorithm in which the cuff is slowly inflated while simultaneously sensing oscillations. Once oscillations are no longer detected, the cuff deflates rapidly and the signals are processed to determine systolic and diastolic pressures.
The vital sign measurement device communicates with a mobile application on a smartphone or tablet via wireless Bluetooth Low Energy (BLE) communication. The healthcare professional can access the patient physiological signs via the mobile application. The Hinlab application on the mobile device displays the blood pressure, SpO2 and pulse rate measurements.
The Hinscope is intended for spot-check vital signs measurement of adult patients in professional healthcare facilities, such as hospitals or skilled nursing facilities. It is intended to be used by trained healthcare professionals.
The applicable subheading for the Hinscope will be 9018.19.9550, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[i]nstruments and appliances used in medical, surgical, dental or veterinary sciences …: [e]lectro-diagnostic apparatus …: [o]ther: [o]ther: [o]ther: [o]ther apparatus.” The general rate of duty will be free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e., 9903.01.24, in addition to subheading 9018.19.9550, HTSUS, listed above.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time, products of China, Hong Kong, and Macau will be subject to an additional ad valorem rate of duty of 10 percent.
At the time of entry, you must report the Chapter 99 heading applicable to your product classification, i.e. 9903.01.25, in addition to subheading 9018.19.9550, HTSUS, listed above. Pursuant to U.S.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N353388).